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Running title: Air pollution and kidney parenchyma cancer 
 
What’s new? 
Ambient air pollution is an established cause of lung cancer. It is of considerable public health interest 
whether air pollution also causes other cancers. A few studies indicated that air pollution might cause 
kidney cancer. These authors investigated a possible link between kidney parenchyma cancer and air 
pollution at the residence of 289,002 participants of 14 European cohorts. They found an increased risk 
in association with particulate matter air pollution, although not statistically significant. 
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Abstract 
Several studies have indicated weakly increased risk for kidney cancer among occupational groups 
exposed to gasoline vapors, engine exhaust, polycyclic aromatic hydrocarbons and other air pollutants, 
although not consistently. It was the aim to investigate possible associations between outdoor air 
pollution at the residence and the incidence of kidney parenchyma cancer in the general population. We 
used data from 14 European cohorts from the ESCAPE study. We geocoded and assessed air pollution 
concentrations at baseline addresses by land-use regression models for particulate matter (PM10, PM2.5, 
PMcoarse, PM2.5 absorbance (soot)) and nitrogen oxides (NO2, NOx), and collected data on traffic. We 
used Cox regression models with adjustment for potential confounders for cohort-specific analyses and 
random effects models for meta-analyses to calculate summary hazard ratios (HRs). The 289,002 
cohort members contributed 4,111,908 person-years at risk. During follow-up (mean 14.2 years) 697 
incident cancers of the kidney parenchyma were diagnosed. The meta-analyses showed higher HRs in 
association with higher PM concentration, e.g. HR=1.57 (95%CI: 0.81-3.01) per 5µg/m3 PM2.5 and 
HR=1.36 (95%CI: 0.84-2.19) per 10-5m-1 PM2.5 absorbance, albeit never statistically significant. The 
HRs in association with nitrogen oxides and traffic density on the nearest street were slightly above 
one. Sensitivity analyses among participants who did not change residence during follow-up showed 
stronger associations, but none were statistically significant. This study provides suggestive evidence 
that exposure to outdoor PM at the residence may be associated with higher risk for kidney parenchyma 
cancer; the results should be interpreted cautiously as associations may be due to chance. 
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INTRODUCTION 
 
A working group established under the International Agency for Research on Cancer recently classified 
outdoor air pollution in general, and particulate matter (PM) in particular, as carcinogenic to humans 1. 
This classification was based on, among others, an extensive review of the epidemiological literature, 
which provided convincing evidence for an association with lung cancer. Positive associations were 
also noted for cancer of the urinary bladder and childhood leukaemia, whereas associations between air 
pollution and other cancers had only been sparsely studied 1. 
 
Over 90% of kidney cancers develop in the kidney parenchyma and the vast majority of these are 
adenocarcinomas (often denoted as renal cell carcinomas); the less than 10% of kidney cancers, which 
develops in the renal pelvis, are primarily of the transitional cell type 2. Worldwide, the incidence rates 
of kidney cancer increased until the mid-1990s when they plateaued or declined in many countries 2. 
Incidence rates of kidney parenchyma cancer are relatively high in Europe with rates between 3 and 15 
per 100,000 in different countries 2. Active tobacco smoking, obesity and hypertension are established 
risk factors for cancer of the kidney parenchyma 2,3 and there is also suggestive evidence for, among 
others, exposure to environmental tobacco smoke 4,5. Several studies of occupational groups, such as 
transport workers, drivers, policemen, metal foundry workers, and gasoline service station workers 
exposed to gasoline vapors, engine exhaust, polycyclic aromatic hydrocarbons, and other air pollutants, 
have indicated weakly increased risk for kidney cancer 6-8, although the literature is neither consistent 9 
nor conclusive 10. Garcia-Perez et al. found higher kidney cancer mortality in Spanish general 
populations exposed to ambient air pollution from incinerators and hazardous waste treatment plants 11 
and a cohort study of a general Danish population found positive but statistically insignificant 
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associations between nitrogen oxides (NOx) at the residence and kidney cancer incidence but no 
association with amount of street traffic near the residence 12. Further, ultrafine particles can translocate 
from the airways to the kidney and other organs of experimental animals 13 and experiments have 
shown that diesel particles can induce cancer-relevant processes in the kidneys 14,15. 
 
We recently reported from the European Study of Cohorts for Air Pollution Effects (ESCAPE) that PM 
in outdoor air with a diameter < 10 µm (PM10) and 2.5 µm (PM2.5) at the residence is associated with 
risk for the development of lung cancer 16 and natural-cause mortality 17.  
 
The aim of the present study was to investigate a possible association between outdoor air pollution and 
the risk for cancer of the kidney parenchyma in general European populations, applying the methods 
developed in ESCAPE. 
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MATERIALS AND METHODS 
 
Design and participants 
The full ESCAPE study included 12 European areas where air pollution measurements were 
performed, land use regression (LUR) models were developed, and adult cohort studies with cancer 
incidence data were located. The present study included the 14 cohorts, located in 10 areas, with 
information on incident cancer, the most important potential confounders, with at least 20 incident 
kidney parenchyma cancer cases during follow-up and where the resources needed for participation 
were available. The 14 cohorts were in Sweden (European Prospective Investigation into Cancer and 
Nutrition[EPIC]-Umeå, Swedish National Study on Aging and Care in Kungsholmen [SNAC-K], 
Stockholm Screening Across the Lifespan Twin Study and TwinGene [SALT], Stockholm 60 years old 
and IMPROVE study [60-y/IMPROVE], Stockholm Diabetes Prevention Program [SDPP]), Norway 
(Oslo Health Study [HUBRO]), Denmark (Diet, Cancer and Health Study [DCH]), the Netherlands 
(EPIC-Monitoring Project on Risk Factors and Chronic Diseases in the Netherlands [MORGEN], 
EPIC-PROSPECT), the United Kingdom (EPIC-Oxford), Austria (Vorarlberg Health Monitoring and 
Prevention Programme [VHM&PP]), Italy (EPIC-Varese, EPIC-Turin) and Spain (EPIC-San 
Sebastian); Figure 1). Our previous study on lung cancer included 312,944 participants of 17 cohorts in 
12 study areas. The present study on kidney parenchyma cancer included 289,002 participants, i.e. a 
large fraction of our previous study. Most of the study areas were large cities and the surrounding 
suburban or rural communities, as specified in the online appendix (pp. 4–13). A pooled analysis of all 
cohort data was not possible due to data-transfer and privacy issues but data from the four Stockholm 
cohorts (SNAC-K, SALT, 60-y/IMPROVE and SDPP) were pooled, and analysed and denoted as one 
cohort (Cardiovascular Effects of Air pollution and Noise in Stockholm [CEANS]) in the following. 
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Similarly, data from the two cohorts from the Netherlands (EPIC-MORGEN and EPIC-PROSPECT) 
were pooled, analysed and denoted as one [EPIC-NL]. Thus, ten cohort data sets were analysed. 
Information on lifestyle etc. among cohort participants was obtained by questionnaires or interviews at 
enrolment (see online appendix, Table S1). The local ethical and data protection authorities approved 
the use of cohort data. All participants signed informed consent forms at enrolment. 
 
Definition of incident cancer of the kidney parenchyma 
We included cancers located in the kidney parenchyma (ICD10/ICDO3: C64). We only included 
primary cancers (i.e. not metastases). The cohort members were followed up for cancer incidence in 
national or local cancer registries. 
 
Exposure assessment 
Annual outdoor air pollution concentrations at the baseline residential addresses of study participants 
were estimated by LUR models in a three-step, standardized procedure that has been described 
elsewhere 18,19. First, PM with an aerodynamic diameter < 10 µm (PM10), PM with aerodynamic 
diameter < 2.5 µm (PM2.5), PM2.5 absorbance (a marker for black carbon and soot), nitrogen dioxide 
(NO2), and nitrogen oxides (NOx) were measured three times during different seasons at locations for 
each cohort population for 1 year between October 2008 and April 2011. Coarse PM was calculated as 
the difference between PM10 and PM2.5. In the Umeå, Varese and San Sebastian areas only NO2 and 
NOx was measured. Results from the three measurements were averaged, adjusting for temporal trends 
using data from a background monitoring site with continuous data 18,20. PM filters were weighed 
before and after each measurement centrally at IRAS, Utrecht University. Second, we collected 
information about potential predictor variables relating to nearby traffic intensity, population/household 
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density and land use from Geographic Information Systems (GIS), and evaluated these to explain 
spatial variation of annual average concentrations using regression modelling 18,19. In general, 
predictors for PM10, PM2.5, NOx and NO2 related to traffic/roads and population/building density. 
Variables related to industry, port and altitude were also predictors in some models. These LUR models 
were evaluated using Leave-One-Out-Cross-Validation, which successively leaves one site out of the 
data and refits the model with the remaining N-1 sites. The models generally explained a large fraction 
of measured spatial variation, the r2 from leave-one-out cross-validation usually falling between 0.60 
and 0.80 16. Finally, we used the models to assess exposure at the baseline address of each cohort 
member. If values of predictor variables for the cohort addresses were outside the range of values for 
the monitoring sites, we truncated the values to the minimum or maximum values at the monitoring 
sites. We truncated to prevent unrealistic predictions (e.g. related to too small distance to roads in GIS) 
and because we did not want to extrapolate the derived model beyond the range, for which it was 
developed. Truncation has been shown to improve predictions at independent sites 21. We also collected 
information on traffic intensity (vehicles/day) on the nearest street. As part of the TRANSPHORM 
project, we used similar methods to predict concentrations of eight elements in PM at participants’ 
baseline addresses 22,23; we describe these procedures in the online appendix (pp. 2). 
 
Statistical analyses 
The association between long-term exposure to air pollution and incidence of kidney parenchyma 
cancer was analysed in each cohort separately at the local centre by common standardized protocols for 
exposure assessment, outcome definition, confounder models and statistical analyses. Cohort-specific 
effect estimates were combined by meta-analysis at the Danish Cancer Society Research Center, 
Copenhagen, Denmark. 
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We fitted Cox proportional hazards regression models for each cohort, with age as the underlying time 
scale and followed up participants from enrolment until the time of a kidney parenchyma cancer 
diagnosis or censoring. We excluded participants with a cancer (except non-melanoma skin cancer) 
before enrolment and censored at the time of death, a diagnosis of any other cancer (except non-
melanoma skin cancer), emigration, or end of follow-up, whichever came first. We censored 
participants with another cancer because cancer treatment and change of life style might change the 
subsequent risk for development of another cancer. Air pollution exposure was analysed as a linear 
variable in three a-priori specified confounder models. Model 1 included sex, calendar time (year of 
enrolment; linear) and age (time axis). Model 2 additionally adjusted for smoking status 
(never/former/current), smoking intensity (g tobacco/day), smoking duration (years), 
occupation/employment status (different definitions, see online appendix pp. 3-13), educational level 
(low, medium, high), body mass index (BMI) (linear, kg/m2) and hypertension (yes/no) (all referring to 
baseline). Model 3 (the main model) further adjusted for area-level socio-economic status. Information 
on at least age, sex, calendar time, smoking status, smoking intensity, smoking duration and BMI was 
available in all cohorts. We provide further information on the available variables and their definition 
and distribution in each cohort in the online appendix (pp. 4-13 and Table S1). Potential confounders 
were based on previous literature on risk factors for kidney cancer and availability. 
 
We undertook a number of sensitivity analyses for each cohort, all with confounder model 3. First, we 
repeated the analyses after restriction to participants who had lived at the baseline address throughout 
the follow-up period, thus reducing misclassification of long-term exposure to air pollution in this sub-
population. Secondly, we added an indicator of degree of urbanization. Thirdly, we tested the linear 
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assumption in the relation between each air pollutant and kidney parenchyma cancer by replacing the 
linear term with a natural cubic spline with three equally spaced inner knots, and compared the model 
fit of the linear and the spline models by the likelihood-ratio test. Fourthly, we repeated the analyses 
using back-extrapolated NO2 and NOx exposure data, which is described further in the online appendix 
(pp. 2-3). 
 
In the meta-analysis, we used random-effects models to summarize the results for cohorts 24. I2 
statistics 25 and p values for the χ2 test from Cochran’s Q were calculated to determine heterogeneity 
among cohort-specific effect estimates.  We used a common STATA (www.stata.com) script for all 
analyses. 
 
 
RESULTS 
Fourteen cohorts in seven European countries contributed to this study. Altogether 289,002 cohort 
members contributed 4,111,908 person-years at risk and 697 incident kidney parenchyma cases were 
registered during follow-up (mean, 14.2 years). The number of participants and cases varied 
considerably, the Austrian cohorts contributing almost half the cases (Table 1). The cohort areas 
represented a wide range of exposures, with 3–11 times higher mean air pollution concentrations in 
some Southern than Northern areas (Table 1). The variation in exposure within study areas was 
substantial, as shown previously 16. The mean age at enrolment varied from 43 to 57 years (Table 1). 
 
The meta-analyses showed higher summary hazard ratios (HRs) in association with higher PM 
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concentration, e.g. HR=1.57 (95% CI: 0.81-3.01) per 5µg/m3 PM2.5 and HR=1.36 (95% CI: 0.84-2.19) 
per 10-5m-1 PM2.5 absorbance (soot), albeit never statistically significant (Table 2). The HRs in 
association with nitrogen oxides and traffic were slightly above one. Adjustment did not affect the 
summary HRs much (Table 2). The summary HRs for PM10, PM coarse and PM2.5 were based on low 
to moderate heterogeneity between cohort-specific results; all p values for heterogeneity were ≥0.10 
(Table 2). For the large VHM&PP cohort, HRs in association with PM2.5 and PM2.5 absorbance were 
lower than one (PM2.5 HR=0.73; 95% CI: 0.47-1.14); all other cohorts showed increased risk in 
association with PM2.5 exposure (Figure 2 and online Figure S1). Analyses based on participants who 
did not change residence during follow-up showed stronger associations, but none was statistically 
significant (Table 3). These results were based on stronger heterogeneity, which were statistically 
significant for PM2.5 and PM10 (p ≤0.01) (Table 3). 
 
The assumption of linearity was not violated (online Table S2). Adjustment for degree of urbanization 
did not affect the results much (online Table S3) and use of back-extrapolated NO2 and NOx data only 
affected the results marginally (online appendix pp. 2-3 and Table S4). 
 
Explorative analyses of 8 PM elements in two particle fractions (PM10 and PM2.5) showed mostly 
elevated HRs. HRs were elevated in both particle fractions for Cu, Fe, Zn, V and Si. With the exception 
of an HR of 2.17 (95% CI: 1.19-3.97) per 100 ng/m3 vanadium in PM10, none of the HRs were 
statistically significant (online Table S5). Restriction to cohort participants who lived at the same 
residence during follow-up provided mostly higher HRs for the PM elements (online Table S5). 
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DISCUSSION 
This study showed elevated summary HRs for kidney parenchyma cancer incidence in association with 
higher concentration of four different measures of PM air pollution, albeit never statistically 
significant. The HRs in association with nitrogen oxides and traffic were close to one. Sensitivity 
analyses among participants who did not change residence during follow-up showed stronger 
associations, but none was statistically significant. 
 
Our study benefited from a large number of cohort participants from general populations with widely 
different levels of air pollution and complete follow-up. The strengths of our study also include the use 
of standardized methods for exposure assessment and data analyses across all cohorts. We adjusted the 
analyses for a number of potential confounders. In particular, all cohort-specific analyses were adjusted 
for the important smoking variables smoking status, smoking intensity and smoking duration, but the 
possibility of residual confounding cannot be excluded. We assessed a comprehensive set of pollutants 
at address-level and the individual exposure assessment was based on actual measurements made in the 
development of LUR models for the detection of within-area contrasts. Since pooling of data across all 
cohorts was not possible we could not take full advantage of the exposure contrasts across Europe. 
 
In the present study, the HRs for kidney parenchyma cancer were actually larger than those reported in 
the ESCAPE study for lung cancer, which were 1.22 (1.03,1.45), 1.18 (0.96,1.46) and 1.12 (0.88,1.42) 
for PM10, PM2.5 and PM2.5 absorbance 
16. The confidence intervals of the HRs for kidney parenchyma 
cancer were wider, however, which is likely due to the smaller number of cases (697 kidney 
parenchyma versus 2095 lung cancer cases); the person time under risk was virtually the same. A 
previous study found an increased HR for kidney cancer in association with NOx at the residence 
12, 
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which was not found in the present study. Our finding of non-significantly elevated HRs could be 
affected by a combination of the number of cancer cases, misclassification of exposure, confounding 
and chance. Several factors may have contributed to misclassification of the exposure. Although our 
LUR models performed well, with leave-one-out-cross-validation r2 values typically between 0.6 and 
0.8 16, any model incorporates some degree of misclassification. Also, we used data on air pollution for 
2008–2011 in developing our LUR models but applied them to baseline addresses mainly 10–15 years 
earlier. Recent research in Rome, the Netherlands and Vancouver has shown that the spatial 
distribution of air pollution is relatively stable over 10–year periods 26-28, a study showed high 
correlations between traffic intensities on Dutch streets over a 10 year period 29 and spatial models for 
black smoke in the United Kingdom provided reasonable predictions even going back to the 1960s 30, 
indicating that more recent estimations reflect also historical exposure contrasts. In our study, exposure 
was assessed at the enrolment address; moving from that address during follow-up might lead to 
misclassification of the exposure relevant to later development of cancer. Our results show stronger 
associations between air pollution and the risk for kidney parenchyma cancer among people who lived 
at the same address throughout follow-up, which would be expected if air pollution truly causes kidney 
parenchyma cancer. Altogether, we would expect the exposure misclassification in our study to be non-
differential and consequently not to create artificial associations but rather to influence the HRs 
towards unity. The previously reported associations between air pollution and all-cause mortality 17 and 
lung cancer 16 using the same exposure assessment method as in the present study indicates that the 
method indeed detects effects of exposure contrasts. 
 
The airways are the primary target organs for inhaled particles but evidence from experimental studies 
with animals shows that ultrafine particles can translocate to other organs, such as the liver, kidneys, 
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heart and brain 13,31-33. Although the amount of particles accumulating in secondary target organs, such 
as the kidney, is many times lower than the lung tissue dose, it may be relevant for carcinogenic 
processes 34,35. Experimental evidence supports that diesel particles induce cancer-relevant processes in 
the kidneys: diesel exhaust particles induced oxidative stress in cultured human kidney cells 14 and 
exacerbated renal oxidative stress, inflammation and DNA damage in mice 15. We are aware of no 
previous studies on outdoor PM air pollution and kidney cancer in general populations.  
 
The explorative analyses of 8 PM elements showed mostly non-significantly elevated HRs for copper, 
iron, zinc, vanadium and silicon for both particle fractions. The vanadium content of PM2.5 was 
significantly associated with risk for kidney parenchyma cancer, with substantially elevated HRs in 
both PM10 and PM2.5. This may point to a specific source of particles. However, we do not want to 
over-interpret the vanadium findings as one significant association is close to what would be expected 
by chance among the 16 tests undertaken for the PM element analyses, given our 5% significance level. 
Each PM element can be considered as representing different air pollution sources with copper, iron 
and zinc being indicators mainly of non-tailpipe traffic emissions such as brake and tyre wear, sulphur 
mainly indicating long-range transport, nickel and vanadium indicating mixed oil-burning and industry, 
silicon crustal material and potassium biomass burning 22,36-38. 
 
The Austrian VHM&PP cohort was the only cohort where PM2.5 and PM2.5 absorbance (soot) was not 
associated with higher risk for kidney parenchyma cancer (Figure 2 and online Supplementary Figure 
S1). This large cohort influenced the summary HRs substantially: without the VHM&PP cohort, the 
summary HR was 1.95 (1.21, 3.14) for PM2.5. We cannot explain the opposite results with any bias or 
design issue related to specifically this cohort; chance might be the explanation. The latter 
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interpretation is supported by the fact that in the lung cancer and all-cause mortality ESCAPE analyses, 
elevated HRs were found for this cohort, that did not affect the summary HRs 16,17. A post-hoc 
explanation could be that the concentrations of vanadium were lowest in this cohort, while vanadium 
was associated with the highest HRs among the analyzed PM elements. 
 
In conclusion, this study provides suggestive evidence that exposure to outdoor PM at the residence 
may be associated with higher risk for kidney parenchyma cancer. The result should be interpreted with 
caution and future studies are needed to confirm or reject this hypothesis. 
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FIGURE LEGENDS 
Figure 1. Areas where cohort members lived, measurements were taken and land-use regression models 
for prediction of air pollution were developed. 
 
Figure 2. Cohort-specific associations between PM2.5 (upper Forest plot, HRs per 5 µg/m
3), NO2 (lower 
Forest plot, HRs per 10 µg/m3) and risk for kidney parenchyma cancer 
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Table 1. Participants, kidney cancer cases, mean air pollution concentrations, and traffic in cohorts. 
Cohort, location Nparticipants Mean age 
at 
baseline 
(years) 
Person-
years at 
risk
 
Ncases
 
PM10 
(µg/m
3
) 
PMcoarse 
(µg/m
3
) 
PM2.5 
(µg/m
3
) 
PM2.5abs 
(10
-5
 m
-1
) 
NO2 
(µg/m
3
) 
NOx 
(µg/m
3
) 
Traffic on nearest 
street (vehicles/day) 
EPIC-Umeå, 
Umeå, Sweden 21 596 46 290 220 30 NA NA NA NA 5.2 8.7 845 
HUBRO, Oslo, 
Norway 17 786 48 151 559 21 13.5 4.0 8.9 1.2 20.9 38.2 2495 
CEANS, 
Stockholm, 
Sweden 17 161 56 179 913 43 14.6 7.1 7.1 0.6 10.7 18.9 1531 
DCH, 
Copenhagen, 
Denmark 37 643 57 556 466 125 17.2 5.7 11.3 1.2 16.4 26.8 3023 
EPIC-NL, the 
Netherlands 30 120 50 355 756 46 25.4 8.5 16.8 1.4 25.2 37.9 1292 
EPIC-Oxford, 
London/Oxford, 
United Kingdom 35 886 45 392 233 22 16.0 6.4 9.8 1.1 24.4 40.8 1392 
VHM&PP, 
Voralberg, 
Austria 103 347 43 1 873 157 324 20.6 6.7 13.6 1.7 19.9 39.9 1685 
EPIC-Varese, 
10 299 52 111 092 29 NA NA NA NA 43.5 86.7 NA 
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Varese, Italy 
EPIC-Turin, 
Turin, Italy 7578 54 108 716 22 46.5 16.5 30.1 3.1 53.2 96.4 4018 
EPIC-San 
Sebastian, San 
Sebastian, Spain 7586 49 92 796 35 NA NA NA NA 23.8 47.2 NA 
 
PM2.5abs, PM2.5absorption 
NA, not available 
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Table 2. Random-effects meta-analyses hazard ratios for kidney parenchyma cancer in association with exposure to six air 
pollutants and a traffic indicator and measures of heterogeneity between underlying cohort-specific results. 
 
Within each cohort, we included only participants without missing data in any of the variables included in model 3, thus using an identical data set for 
analyses with all three models within the same cohort. 
 
1 The four Stockholm cohorts were pooled and only count one. Similarly, the two Dutch EPIC cohorts were pooled and only count one. 
2
 Model 1: age (time scale in Cox model), sex, calendar time 
3Model 2: Model 1 + smoking status, smoking intensity, smoking duration, occupation/employment status, educational level, BMI, hypertension 
4
Model 3: Model 2 + area-level socio-economic status 
5 Cochran test for heterogeneity 
   HR (95% CI) Measures of heterogeneity 
between cohorts 
Exposure Increase No. of 
Cohorts
1 
Model 1
2
 Model 2
3
 Model 3
4
 Model 3 
      I
2
 (%) p
5
 
PM10 10 µg/m
3
 7 1.40 (0.87-1.51) 1.39 (0.87-2.20) 1.29 (0.85-1.96) 25 0.24 
PM2.5 5 µg/m
3
 7 1.46 (0.81-2.61) 1.48 (0.81-2.70) 1.57 (0.81-3.01) 44 0.10 
PMcoarse 5 µg/m
3
 7 1.11 (0.82-1.51) 1.12 (0.80-1.56) 1.08 (0.80-1.45) 0 0.53 
PM2.5 absorbance 10
-5
 m
-1
  7 1.43 (0.89-2.31) 1.54 (0.90-2.63) 1.36 (0.84-2.19) 25 0.24 
NO2 10 µg/m
3
 10 1.06 (0.93-1.21) 1.10 (0.94-1.28) 1.04 (0.92-1.19) 13 0.32 
NOx 20 µg/m
3
 10 1.03 (0.93-1.14) 1.04 (0.94-1.15) 1.03 (0.93-1.14) 0 0.69 
Traffic density on  
nearest street 
5000 vehicles 
per day 
8 1.03 (0.95-1.11) 1.02 (0.95-1.10) 1.02 (0.95-1.10) 0 0.87 
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Table 3. Random-effects meta-analyses hazard ratios for kidney parenchyma cancer in association with exposure to six air pollutants and a 
traffic indicator for all participants and for those with the same residence during the whole follow-up period (non-movers). All results derive 
from analyses with confounder model 3
1
. 
 
 
 
 
 
 
 
 
 
 
1 Model 3: age (time scale in Cox model), sex, calendar time, smoking status, smoking intensity, smoking duration, occupation/employment status, educational level, 
BMI, hypertension, area-level socio-economic status 
2 EPIC-Umeå, EPIC-Netherlands, EPIC-Turin and EPIC-San Sebastian had no information on changes of residence during follow-up. 
3
 Cochran test for heterogeneity 
    
HR (95% CI) 
 Measures of heterogeneity 
between cohorts 
Exposure Increase  All cohorts; all 
participants (repeated 
for comparison) 
Cohorts with non-
mover information
2
; 
all participants 
Cohorts with non- 
mover information;  
non-movers 
 Cohorts with non- 
mover information;  
non-movers 
       I
2
 (%) p-value
3
 
PM10 10 µg/m
3
  1.29 (0.85-1.96) 1.33 (0.82-2.17) 1.72 (0.73-4.08)  68 0.01 
PM2.5 5 µg/m
3
  1.57 (0.81-3.01) 1.73 (0.72-4.18) 2.62 (0.68-10.1)  74 0.003 
PMcoarse 5 µg/m
3
  1.08 (0.80-1.45) 1.15 (0.82-1.59) 1.45 (0.92-2.30)  20 0.29 
PM2.5 absorbance 10
-5
 m
-1
   1.36 (0.84-2.19) 1.37 (0.71-2.65) 1.67 (0.75-3.71)  38 0.16 
NO2 10 µg/m
3
  1.04 (0.92-1.19) 0.99 (0.86-1.15) 1.08 (0.82-1.43)  51 0.07 
NOx 20 µg/m
3
  1.03 (0.93-1.14) 1.00 (0.90-1.12) 1.04 (0.81-1.34)  51 0.07 
Traffic density on  
nearest road 
5000 
vehicles 
per day 
 1.02 (0.95-1.10) 1.03 (0.95-1.11) 1.04 (0.94-1.16)  0 0.74 
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Figure 1. Areas where cohort members lived, measurements were taken and 
land-use regression models for prediction of air pollution were developed. 
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Figure 2. Cohort-specific associations between PM2.5 (upper Forest plot, HRs per 
5 µg/m3), NO2 (lower Forest plot, HRs per 10 µg/m3) and risk for kidney 
parenchyma cancer 
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